Skip to ContentSkip to Navigation
How to find us M.S.M.M. Hashim

Publications

Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions

TIME-TO-TREATMENT DISCONTINUATION (TTD) AS A PRAGMATIC PREDICTOR OF OVERALL SURVIVAL (OS) IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) - REAL-WORLD PERSPECTIVE

Association between hazard ratios of surrogate time-to-event endpoints and overall survival in advanced/metastatic cancers

Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments?: An Application in Advanced Non-Small Cell Lung Cancer

Read more